Abstract:Monoterpene indole alkaloids (MIAs) are a class of natural products comprised of thousands of structurally unique bioactive compounds with significant therapeutic values. Due to difficulties associated with isolation from native plant species and organic synthesis of these structurally complex molecules, microbial production of MIAs using engineered hosts are highly desired. In this work, we report the engineering of fully integrated Saccharomyces cerevisiae strains that allow de novo access to strictosidine, the universal precursor to thousands of MIAs at 30-40 mg/L. The optimization efforts were based on a previously reported yeast strain that is engineered to produce high titers of the monoterpene precursor geraniol through compartmentalization of mevalonate pathway in the mitochondria. Our approaches here included the use of CRISPR-dCas9 interference to identify mitochondria diphosphate transporters that negatively impact the titer of the monoterpene, followed by genetic inactivation; the overexpression of transcriptional regulators that increase cellular respiration and mitochondria biogenesis. Strain construction included the strategic integration of genes encoding both MIA biosynthetic and accessory enzymes into the genome under a variety of constitutive and inducible promoters. Following successful de novo production of strictosidine, complex alkaloids belonging to heteroyohimbine and corynantheine families were reconstituted in the host with introduction of additional downstream enzymes. We demonstrate that the serpentine/alstonine pair can be produced at ∼5 mg/L titer, while corynantheidine, the precursor to mitragynine can be produced at ∼1 mg/L titer. Feeding of halogenated tryptamine led to the biosynthesis of analogs of alkaloids in both families. Collectively, our yeast strain represents an excellent starting point to further engineer biosynthetic bottlenecks in this pathway and to access additional MIAs and analogs through microbial fermentation. One sentence summary: An Saccharomyces cerevisiae-based microbial platform was developed for the biosynthesis of monoterpene indole alkaloids, including the universal precursor strictosidine and further modified heteroyohimbine and corynantheidine alkaloids.

Intein-mediated Temperature Control for Complete Biosynthesis of Sanguinarine and Its Halogenated Derivatives in Yeast

Construction of ajmalicine and sanguinarine de novo biosynthetic pathways using stable integration sites in yeast

De Novo Biosynthesis of Vindoline and Catharanthine in Saccharomyces cerevisiae

Complete biosynthesis of noscapine and halogenated alkaloids in yeast

Combining Protein and Organelle Engineering for Linalool Overproduction in Saccharomyces Cerevisiae.

Biosynthesis and Engineering of Kaempferol in Saccharomyces Cerevisiae

High titer production of gastrodin enabled by systematic refactoring of yeast genome and an antisense-transcriptional regulation toolkit

Engineered biosynthesis of plant heteroyohimbine and corynantheine alkaloids in Saccharomyces cerevisiae

Efficient production of vindoline from tabersonine by metabolically engineered Saccharomyces cerevisiae

Metabolic Engineering of Saccharomyces Cerevisiae for Production of 8-Dimenthylally Naringenin

Engineering yeast for the production of breviscapine by genomic analysis and synthetic biology approaches

Combinatorial metabolic engineering of Bacillus subtilis enables the efficient biosynthesis of isoquercitrin from quercetin

De novo production of protoberberine and benzophenanthridine alkaloids through metabolic engineering of yeast

Optimizing yeast for high-level production of kaempferol and quercetin

Astaxanthin Overproduction in Yeast by Strain Engineering and New Gene Target Uncovering

Metabolic Engineering of Microorganisms for the Production of Flavonoids

Programmable Biosynthesis of Plant-Derived 4'-Deoxyflavone Glycosides by an Unconventional Yeast Consortium

Green production of silybin and isosilybin by merging metabolic engineering approaches and enzymatic catalysis

Metabolic engineering of Saccharomyces cerevisiae for high-level production of gastrodin from glucose

Optimizing Oleaginous Yeast Cell Factories for Flavonoids and Hydroxylated Flavonoids Biosynthesis

Effects of codon optimization, N-terminal truncation and gene dose on the heterologous expression of berberine bridge enzyme